cancer immunotherapy
From accidental to essential — How PairX Bio revolutionises cancer immunotherapies
From accidental to essential — How PairX Bio revolutionises cancer immunotherapies
The startup focuses its efforts on cancer treatment by targeting shared tumour antigens.
CellVec enters strategic partnership with Peter MacCallum Cancer Centre
The partnership will enable high-potential research on cancer immunotherapy in Asia Pacific.
Most Read
1. Hong Kong seeks prescription for nursing shortage 2. Global pharmaceutical data and analytics market to double by 2028 3. ASEAN medical tourism set to outpace global revenue growth 4. Australia announces $25.5m 2024 Rapid Applied Research Translation grant 5. Thomson and Monash University Malaysia partner for joint researchResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
The trade show, which was held in Singapore, successfully brought together over 13,000 visionary digital health innovators, government leaders, and industry pioneers from the medical and healthcare sectors.
